Fig. 1From: Matrine combined with cisplatin synergistically inhibited urothelial bladder cancer cells via down-regulating VEGF/PI3K/Akt signaling pathwayThe 2D structure of matrine (a) and cisplatin (b) (from PubChem compound http://pubchem.ncbi.nlm.nih.gov/)Back to article page